MENU
EXEL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Exelixis (EXEL) Earnings Date & Reports

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

EXEL is expected to report earnings to fall 24.63% to 46 cents per share on August 12

Exelixis EXEL Stock Earnings Reports
Q2'25
Est.
$0.47
Q1'25
Beat
by $0.25
Q4'24
Beat
by $0.16
Q3'24
Beat
by $0.13
Q2'24
Beat
by $0.53
The last earnings report on May 13 showed earnings per share of 62 cents, beating the estimate of 37 cents. With 163.85K shares outstanding, the current market capitalization sits at 11.55B.
View a ticker or compare two or three
EXEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of small molecule therapies for the treatment of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1851 Harbor Bay Parkway
Phone
+1 650 837-7000
Employees
1310
Web
https://www.exelixis.com